We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+22.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$68.5B
AUM Growth
+$9.41B
Cap. Flow
-$1.48B
Cap. Flow %
-2.16%
Top 10 Hldgs %
11.5%
Holding
2,417
New
97
Increased
651
Reduced
820
Closed
64

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$694M
2
BNY
Bank of New York Mellon
BNY
+$668M
3
MRSH
Marsh
MRSH
+$609M
4
DIS icon
Walt Disney
DIS
+$140M
5
TFC icon
Truist Financial
TFC
+$128M

Sector Composition

Rank Sector Weight
1 Technology 18.62%
2 Healthcare 15.47%
3 Financials 13.03%
4 Industrials 11.38%
5 Consumer Discretionary 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PING
2026
DELISTED
Ping Identity Holding Corp.
PING
$43K ﹤0.01%
1,493
CNS icon
2027
Cohen & Steers
CNS
$4.18B
$42K ﹤0.01%
561
-1,441
-72% -$95.1K
SPHR icon
2028
Sphere Entertainment
SPHR
$4.92B
$42K ﹤0.01%
400
ATSG
2029
DELISTED
Air Transport Services Group
ATSG
$42K ﹤0.01%
+1,328
New +$38.8K
CVA
2030
DELISTED
Covanta Holding Corporation
CVA
$42K ﹤0.01%
3,215
AMWD
2031
DELISTED
American Woodmark
AMWD
$41K ﹤0.01%
435
BBSI icon
2032
Barrett Business Services
BBSI
$983M
$41K ﹤0.01%
2,400
SIG icon
2033
Signet Jewelers
SIG
$3.75B
$41K ﹤0.01%
1,500
-11,300
-88% -$289K
CFFN icon
2034
Capitol Federal Financial
CFFN
$1.08B
$40K ﹤0.01%
3,169
CLBK icon
2035
Columbia Financial
CLBK
$1.13B
$40K ﹤0.01%
2,586
LXRX icon
2036
Lexicon Pharmaceuticals
LXRX
$1.03B
$40K ﹤0.01%
11,697
NPO icon
2037
Enpro
NPO
$6.74B
$40K ﹤0.01%
531
SRCE icon
2038
1st Source
SRCE
$2.08B
$40K ﹤0.01%
987
HWKN icon
2039
Hawkins
HWKN
$2.89B
$39K ﹤0.01%
1,492
PRDO icon
2040
Perdoceo Education
PRDO
$1.98B
$39K ﹤0.01%
3,050
SRRK icon
2041
Scholar Rock
SRRK
$5.91B
$39K ﹤0.01%
810
DOMO icon
2042
Domo
DOMO
$164M
$38K ﹤0.01%
595
LNN icon
2043
Lindsay Corp
LNN
$1.15B
$38K ﹤0.01%
292
NVRI icon
2044
Enviri
NVRI
$625M
$38K ﹤0.01%
2,118
MDP
2045
DELISTED
Meredith Corporation
MDP
$38K ﹤0.01%
1,997
ACMR icon
2046
ACM Research
ACMR
$5.28B
$37K ﹤0.01%
1,371
AMKR icon
2047
Amkor Technology
AMKR
$14.8B
$37K ﹤0.01%
2,439
CWK icon
2048
Cushman & Wakefield Ltd
CWK
$3.08B
$37K ﹤0.01%
2,501
EPAC icon
2049
Enerpac Tool Group
EPAC
$1.78B
$37K ﹤0.01%
1,627
OXY.WS icon
2050
Occidental Petroleum Corp Warrants
OXY.WS
$32B
$37K ﹤0.01%
5,382

Similar funds

Macquarie Group's Q4 2020 Portfolio in Review

As of Q4 2020, Macquarie Group held 2,417 positions worth $68.5B, up 16% from $59.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group's Q4 2020 filing shows 97 new, 651 increased, 820 reduced and 64 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M. The largest sale was Pfizer, an estimated $694M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Macquarie Group's largest Q4 2020 buy was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M.
  • Macquarie Group added most to Discover Financial Services in Q4 2020, an estimated $613M increase.
  • Macquarie Group's biggest Q4 2020 reduction was Pfizer, cutting an estimated $694M.
  • Macquarie Group fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $64.8M.
  • Macquarie Group's ten largest holdings make up 11% of its $68.5B portfolio in Q4 2020.
  • Macquarie Group opened 97 new positions and closed 64 in Q4 2020.
  • Macquarie Group's portfolio value rose 16% quarter-over-quarter to $68.5B.

Based on Macquarie Group's 13F filing for Q4 2020, filed 16 Feb 2021.